Time–kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin

Colistin: an update on the antibiotic of the 21st century

(2012) Silpak Biswas et al.   Expert Review of Anti-Infective Therapy

Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients

(2012) Zoe E. Athanassa et al.   INTENSIVE CARE MEDICINE

Meropenem Penetration into Epithelial Lining Fluid in Mice and Humans and Delineation of Exposure Targets

(2011) G. L. Drusano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination therapies for combating antimicrobial resistance

(2011) Michael A Fischbach   CURRENT OPINION IN MICROBIOLOGY

In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time–kill methodology

(2011) Michael Kresken et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression

(2010) A. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of Levofloxacin in a Murine Pneumonia Model of Pseudomonas aeruginosa Infection: Determination of Epithelial Lining Fluid Targets

(2009) A. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Acinetobacter baumannii

(2008) T.-P. Lim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Clarithromycin in Patients with Sepsis and Ventilator‐Associated Pneumonia

(2008) Evangelos J. Giamarellos‐Bourboulis et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006

(2008) George G. Zhanel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE